Trading biophama companies before a catalyst event, if done correctly, can be a very profitable proposition. Some traders and investors who enjoy bringing more risk into play often times will hold through the actual catalyst event. While this does bring…
Tag: biotech
Small Cap Bio-Pharmas For Possible Long Side Trades
With some added confidence shown by investors yesterday, it’s a good time to look at some “risk on” small cap bio-pharma stocks that I feel offer good upside for both swing trades and longer term holds. However, with the looming…
November 10 Biotech Update
This past week was a bit rough on the overall markets as on Tuesday, the markets seemed to bet on a Romney win, only to sell off the next day on news of an Obama win. The good news for…
Amicus Therapeutics Should See a Big Upside Move On Positive Phase 3 Data
One company that has really received a ton of attention lately has been Sarepta Therapeutics (SRPT). Only a few weeks ago, the stock was trading in the $3 to $4 range. On 10/3/12, the company announced that it received positive…
